Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy.

MLA

Eissler, Nina, et al. “Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy.” Biomedicines, vol. 12, no. 5, May 2024. EBSCOhost, https://doi.org/10.3390/biomedicines12051088.

APA

Eissler, N., Altena, R., Alhuseinalkhudhur, A., Bragina, O., Feldwisch, J., Wuerth, G., Loftenius, A., Brun, N., Axelsson, R., Tolmachev, V., Sörensen, J., & Frejd, F. Y. (2024). Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy. Biomedicines, 12(5). https://doi.org/10.3390/biomedicines12051088

Chicago

Eissler, Nina, Renske Altena, Ali Alhuseinalkhudhur, Olga Bragina, Joachim Feldwisch, Guido Wuerth, Annika Loftenius, et al. 2024. “Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy.” Biomedicines 12 (5). doi:10.3390/biomedicines12051088.